Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Travis Monnell · SciRah

Researcher profile · Semantic Scholar

Travis Monnell

Share profile

Travis Monnell — researcher profile on SciRah

h-index: 8
Works: 18
Citations: 667

Most-cited papers

ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth
D. Mitchell, Eileen G. Pobre, A. Mulivor, Asya V. Grinberg +8 more
2010Molecular Cancer Therapeutics166 citations Open access
Semantic Scholar
Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type.
Samuel M. Cadena, Kathleen N. Tomkinson, Travis Monnell, Matthew Spaits +4 more
2010Journal of applied physiology141 citations Open access
Semantic Scholar
Efficient specification of interneurons from human Pluripotent stem cells by dorsoventral and rostrocaudal modulation
Taegon Kim, Rui-Qin Yao, Travis Monnell, Jun-Hyeong Cho +8 more
2014Stem Cells115 citations Open access
Semantic Scholar
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses
Naniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, P. Shaw +11 more
2024Nature Communications86 citations Open access
Semantic Scholar
A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health.
A. Koncarevic, Milton R. Cornwall-Brady, A. Pullen, M. Davies +17 more
2010Endocrinology73 citations
Semantic Scholar
XMT-2056, a HER2-Directed STING Agonist Antibody–Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
R. Bukhalid, Jeremy R Duvall, Kelly Lancaster, Kalli C. Catcott +17 more
2025Clinical Cancer Research42 citations Open access
Semantic Scholar
Abstract 3503: XMT-2056, a HER2-targeted Immunosynthen STING-agonist antibody-drug conjugate, binds a novel epitope of HER2 and shows increased anti-tumor activity in combination with trastuzumab and pertuzumab
Jeremy R. Duvall, R. Bukhalid, N. Cetinbas, Kalli C. Catcott +24 more
2022Cancer Research22 citations
Semantic Scholar
Abstract 1738: XMT-2056, a well-tolerated, Immunosynthen-based STING-agonist antibody-drug conjugate which induces anti-tumor immune activity
Jeremy R. Duvall, R. Bukhalid, N. Cetinbas, Kalli C. Catcott +25 more
2021Immunology17 citations
Semantic Scholar
Abstract 2114: Tumor cell-targeted STING-agonist antibody-drug conjugates achieve potent anti-tumor activity by delivering STING agonist specifically to tumor cells andFcγRI-expressing subset of myeloid cells
N. Cetinbas, Kalli C. Catcott, Travis Monnell, Jahna Soomer-James +13 more
2022Cancer Research7 citations
Semantic Scholar
Abstract 1773: Tumor cell-intrinsic STING pathway activation leads to robust induction of Type III Interferons and contributes to the anti-tumor activity elicited by STING agonism
N. Cetinbas, Travis Monnell, Kalli C. Catcott, Winnie Lee +14 more
2021Immunology2 citations
Semantic Scholar
1053 XMT-2056, a HER2-targeted immunosynthen STING agonist antibody-drug conjugate, induces anti-tumor activity at low doses in preclinical models
N. Cetinbas, Kelly Lancaster, Travis Monnell, Kalli C. Catcott +4 more
2024Regular and Young Investigator Award Abstracts1 citations Open access
Semantic Scholar
620 Tumor cell-intrinsic STING pathway is activated in the presence of cues from immune cells and contributes to the anti-tumor activity of tumor cell-targeted STING agonist antibody-drug conjugates
N. Cetinbas, Travis Monnell, Winnie Lee, Kalli C. Catcott +16 more
2020Journal for ImmunoTherapy of Cancer1 citations Open access
Semantic Scholar
typeskeletal muscle growth independent of fiber Administration of a soluble activin type IIB receptor
L. Lachey, Kathryn W. Underwood, R. Pearsall, M. Cadena +22 more
20150 citations
Semantic Scholar
A Soluble BMP Antagonist Polypeptide Increases Bone Mass and Improves Bone Strength
N. Solban, Milton R. Cornwall-Brady, Yoshimi Kawamoto, D. Sako +10 more
20100 citations
Semantic Scholar
RAP-536 Accelerates Recovery From Chemotherapy-Induced Anemia (CIA) without Promoting Tumor Growth In Murine Models of Cancer and CIA
Samuel M. Cadena, R. Suragani, D. Mitchell, J. Ucran +6 more
20100 citations
Semantic Scholar
Abstract B5: ACE‐041, a soluble activin receptor‐like kinase‐1 fusion protein, is a novel antiangiogenic agent
D. Mitchell, Eileen G. Pobre, A. Mulivor, Asya V. Grinberg +8 more
20090 citations
Semantic Scholar
Administration of a Novel GDF Trap Prevents Anemia Induced by Renal Insufficiency and Augments Recovery From Blood Loss.
Samuel M. Cadena, D. Mitchell, J. Ucran, K. Liharska +5 more
20090 citations
Semantic Scholar
Treatment with RAP-011 (A soluble activin receptor type IIA) increases bone mineral density in mice with prior bisphosphonate exposure
R. Pearsall, M. Mangini, Milton R. Cornwall-Brady, Travis Monnell +5 more
20080 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Kathryn W. Underwood×9
Invite
Kathryn W. Underwood — researcher profile on SciRah
R. Pearsall×8
Invite
R. Pearsall — researcher profile on SciRah
Kalli C. Catcott×8
Invite
Kalli C. Catcott — researcher profile on SciRah
R. Bukhalid×8
Invite
R. Bukhalid — researcher profile on SciRah

×8

Invite

T. Lowinger — researcher profile on SciRah

Invite

M. Damelin — researcher profile on SciRah

Ravindra Kumar×7

Invite

Ravindra Kumar — researcher profile on SciRah

Invite

D. Toader — researcher profile on SciRah

Joshua D Thomas×6

Invite

Joshua D Thomas — researcher profile on SciRah

Keith W Bentley×6

Invite

Keith W Bentley — researcher profile on SciRah

Invite

N. Cetinbas — researcher profile on SciRah

Invite

J. Ucran — researcher profile on SciRah